New map changes understanding of immune cells in the brain

A new international study has mapped a type of immune cell, the microglia, in the human and mouse brain for the first time. Microglia are thought to play a role in the progression of MS. This research has changed the understanding of how these cells function, and has important implications for MS.

Early intensive treatment gives better outcomes

New study shows that early use of high efficacy treatment for MS improves long term disability outcomes, rather than starting on a moderately effective therapy and escalating to a stronger medication.

Food allergies may be linked to more MS relapses

In a recent study, scientists have shown that people with MS who have food allergies are more likely to experience clinical attacks and lesions in the brain than those without allergies or with other allergies that are unrelated to food.

Research Australia presents award to developer of world’s largest MS database

Helmut Butzkueven, who led the development of MSBase with support from MS Research Australia, has received the Data Innovation Award.

Study shows taking MS medications as directed is better for overall health

Canadian research reveals the positive effects of taking MS medications as prescribed on a person's general health

Discovering how immune cells get into the brain in MS

Study reveals important mechanism that allows immune cells to attack myelin in MS

MS Australia publishes first report on MS Specialist Nurses in Australia

A major investigation into the critical role of MS Specialist Nurses in Australia could support MS Australia’s advocacy work to increase funding for MSSNs

Art University redecorates facilities of Brazilian MS Association

Students and staff from "Universidade Futura do Pintor" renovated the facilities as part of a partnership between the two organisations

2017 McDonald Fellowship and Du Pré grant recipients announced

MSIF is proud to announce the recipients of the 2017 McDonald fellowships and Du Pre grants

A new potential biomarker for the diagnosis of MS

A new small study has discovered molecules in the blood that are specific to people with MS, and can distinguish between relapsing remitting and progressive MS.